GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » QHSLab Inc (OTCPK:USAQ) » Definitions » ROIC %

USAQ (QHSLab) ROIC % : 10.78% (As of Sep. 2024)


View and export this data going back to 1990. Start your Free Trial

What is QHSLab ROIC %?

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. QHSLab's annualized return on invested capital (ROIC %) for the quarter that ended in Sep. 2024 was 10.78%.

As of today (2024-12-16), QHSLab's WACC % is 9.69%. QHSLab's ROIC % is 2.51% (calculated using TTM income statement data). QHSLab earns returns that do not match up to its cost of capital. It will destroy value as it grows.


QHSLab ROIC % Historical Data

The historical data trend for QHSLab's ROIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

QHSLab ROIC % Chart

QHSLab Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -269.61 -36.93 -18.99 -7.06

QHSLab Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
ROIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -4.09 -5.58 1.61 3.54 10.78

Competitive Comparison of QHSLab's ROIC %

For the Medical Devices subindustry, QHSLab's ROIC %, along with its competitors' market caps and ROIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


QHSLab's ROIC % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, QHSLab's ROIC % distribution charts can be found below:

* The bar in red indicates where QHSLab's ROIC % falls into.



QHSLab ROIC % Calculation

QHSLab's annualized Return on Invested Capital (ROIC %) for the fiscal year that ended in Dec. 2023 is calculated as:

ROIC % (A: Dec. 2023 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (A: Dec. 2022 ) + Invested Capital (A: Dec. 2023 ))/ count )
=-0.24 * ( 1 - 0% )/( (3.292 + 3.503)/ 2 )
=-0.24/3.3975
=-7.06 %

where

QHSLab's annualized Return on Invested Capital (ROIC %) for the quarter that ended in Sep. 2024 is calculated as:

ROIC % (Q: Sep. 2024 )
=NOPAT/Average Invested Capital
=Operating Income * ( 1 - Tax Rate % )/( (Invested Capital (Q: Jun. 2024 ) + Invested Capital (Q: Sep. 2024 ))/ count )
=0.356 * ( 1 - 0% )/( (3.343 + 3.263)/ 2 )
=0.356/3.303
=10.78 %

where

Note: The Operating Income data used here is four times the quarterly (Sep. 2024) data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


QHSLab  (OTCPK:USAQ) ROIC % Explanation

ROIC % measures how well a company generates cash flow relative to the capital it has invested in its business. It is also called ROC %. The reason book values of debt and equity are used is because the book values are the capital the company received when issuing the debt or receiving the equity investments.

There are four key components to this definition. The first is the use of operating income or EBIT rather than net income in the numerator. The second is the tax adjustment to this operating income or EBIT, computed as a hypothetical tax based on an effective or marginal tax rate. The third is the use of book values for invested capital, rather than market values. The final is the timing difference; the capital invested is from the end of the prior year whereas the operating income or EBIT is the current year's number.

Why is ROIC % important?

Because it costs money to raise capital. A firm that generates higher returns on investment than it costs the company to raise the capital needed for that investment is earning excess returns. A firm that expects to continue generating positive excess returns on new investments in the future will see its value increase as growth increases, whereas a firm that earns returns that do not match up to its cost of capital will destroy value as it grows.

As of today, QHSLab's WACC % is 9.69%. QHSLab's ROIC % is 2.51% (calculated using TTM income statement data).


Be Aware

Like ROE % and ROA %, ROIC % is calculated with only 12 months of data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.


QHSLab ROIC % Related Terms

Thank you for viewing the detailed overview of QHSLab's ROIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


QHSLab Business Description

Traded in Other Exchanges
N/A
Address
901 Northpoint Parkway, Suite 302, West Palm Beach, FL, USA, 33407
QHSLab Inc is a medical device company providing digital healthcare solutions and point-of-care-diagnostic tests to primary care physicians. The company is a medical device technology and software as a service (SaaS) company focused on enabling primary care physicians (PCPs) to increase their revenues by providing them with relevant, value-based tools to evaluate and treat chronic disease as well as provide preventive care through reimbursable procedures.
Executives
Troy James Grogan director, 10 percent owner, officer: CEO/Director 5480 N OCEAN DR B1D, SINGER ISLAND FL 33404
Richard J Rubin director, 10 percent owner, officer: CEO & Chairman 90 JOHN STREET, SUITE 626, NEW YORK NY 10038

QHSLab Headlines

From GuruFocus

QHSLab. Issues Update and Investor Presentation May 2022

By GuruFocusNews GuruFocusNews 07-08-2022